Search

Displaying results 4501 - 4510 of 10000 in total
  1. Drug

    Broxitalamic acid

    go.drugbank.com/drugs/DB20561
    Experimental

    Broxitalamic acid is a small molecule drug. Broxitalamic acid has a monoisotopic molecular weight of 499.82 Da.

  2. Drug

    Aceburic acid

    go.drugbank.com/drugs/DB20668
    Experimental

    Aceburic acid is a small molecule drug. Aceburic acid has a monoisotopic molecular weight of 146.06 Da.

  3. Drug

    Tibric acid

    go.drugbank.com/drugs/DB20908
    Experimental

    Tibric acid is a small molecule drug. Tibric acid has a monoisotopic molecular weight of 331.06 Da.

  4. Drug

    Iomeglamic acid

    go.drugbank.com/drugs/DB21167
    Experimental

    Iomeglamic acid is a small molecule drug. Iomeglamic acid has a monoisotopic molecular weight of 613.81 Da.

  5. Drug

    Kainic acid

    go.drugbank.com/drugs/DB21189
    Experimental

    Kainic acid is a small molecule drug. Kainic acid has a monoisotopic molecular weight of 213.1 Da.

  6. Drug

    Dexamethasone acefurate

    go.drugbank.com/drugs/DB21317
    Experimental

    Dexamethasone acefurate is a small molecule drug. Dexamethasone acefurate has a monoisotopic molecular weight of 528.22 Da.

  7. Drug

    Tiazotic acid

    go.drugbank.com/drugs/DB21408
    Experimental

    Tiazotic acid is a small molecule drug. Tiazotic acid has a monoisotopic molecular weight of 173.03 Da.

  8. Drug

    Oxiniacic acid

    go.drugbank.com/drugs/DB21422
    Experimental

    Oxiniacic acid is a small molecule drug. Oxiniacic acid has a monoisotopic molecular weight of 139.03 Da.

    Synonyms: Nicotinic acid N-oxide
  9. Drug

    Eflapegrastim

    go.drugbank.com/drugs/DB15001
    ApprovedInvestigational

    in which the patient develops an infection during a period of significant neutropenia. … [L43135] Eflapegrastim is a form of recombinant human G-CSF comprising a human G-CSF analog coupled to the Fc fragment of human IgG4 via a polyethylene glycol linker.

  10. Drug

    Ustekinumab

    go.drugbank.com/drugs/DB05679
    ApprovedInvestigational

    Ustekinumab is a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against interleukin(IL)-12 and IL-23, which are cytokines that are involved in immune and inflammatory responses. … [A187349] It is a targeted biologic disease-modifying anti-rheumatic drug (bDMARDs) that is used in the management of various inflammatory conditions that involve the activation of IL-12 and IL-23 signalling